SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Evolving Role of the Medicinal Chemist
8 references·0 citing·24 second hop
The Evolving Role of the Medicinal Chemist (2016)The Evolving Role of the Medicinal ChemistProfessional Translational Research: A New Hybrid Paradigm in Early Drug Discovery (2015)Professional Translational Re…Medicinal Chemists of the 21st Century—Who Are We and Where to Go? (2015)Medicinal Chemists of the 21s…Academic drug discovery within the United Kingdom: a reassessment (2015)Academic drug discovery withi…2014 FDA drug approvals (2015)2014 FDA drug approvalsAcademic drug discovery centres: the economic and organisational sustainability of an emerging model (2014)Academic drug discovery centr…UK academic drug discovery (2013)UK academic drug discoveryBringing together the academic drug discovery community (2013)Bringing together the academi…US academic drug discovery (2011)US academic drug discoveryDrug Discovery: A Modern Decathlon (2013)Lessons from 60 years of pharmaceutical innovation (2009)The importance of new companies for drug discovery: origins of a decade of new drugs (2010)The Role of Public-Sector Research in the Discovery of Drugs and Vaccines (2011)Discovery of Innovative Therapeutics: Today’s Realities and Tomorrow’s Vision. 2. Pharma’s Challenges and Their Commitment to Innovation (2014)Racing to define pharmaceutical R&D external innovation models (2014)Mitigating risk in academic preclinical drug discovery (2015)Priorities in Scientific Discovery: A Chapter in the Sociology of Science (1957)Toward a new economics of science (1994)Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups (2003)Open for collaboration: an academic platform for drug discovery and development at SciLifeLab (2016)How Much Longer Will We Put Up With $100,000 Cancer Drugs? (2017)The endless frontier? The recent increase of R&D productivity in pharmaceuticals (2020)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)Open innovation in early drug discovery: roadmaps and roadblocks (2015)The academic–industrial complex: navigating the translational and cultural divide (2017)Trait and state biomarkers for psychiatric disorders: Importance of infrastructure to bridge the gap between basic and clinical research and industry (2018)Believe it or not: how much can we rely on published data on potential drug targets? (2011)The productivity crisis in pharmaceutical R&D (2011)Industry–Academic Relationship in a New Era of Drug Discovery (2016)Ten Years of Medicinal Chemistry (2005–2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public–Private Partnerships (2016)Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options (2022)2015 FDA drug approvals (2016)Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022) (2025)
this work references cited by second hop

References

  • 20152014 FDA drug approvals113 cited
  • 2011US academic drug discovery101 cited
  • 2013Bringing together the academic drug discovery community60 cited
  • 2013UK academic drug discovery32 cited
  • 2015Academic drug discovery within the United Kingdom: a reassessment25 cited
  • 2014Academic drug discovery centres: the economic and organisational sustainability of an emerging model25 cited
  • 2015Medicinal Chemists of the 21st Century—Who Are We and Where to Go?9 cited
  • 2015Professional Translational Research: A New Hybrid Paradigm in Early Drug Discovery5 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work